1. Home
  2. AQST vs SMC Comparison

AQST vs SMC Comparison

Compare AQST & SMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • SMC
  • Stock Information
  • Founded
  • AQST 2004
  • SMC 2009
  • Country
  • AQST United States
  • SMC United States
  • Employees
  • AQST N/A
  • SMC N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • SMC
  • Sector
  • AQST Health Care
  • SMC
  • Exchange
  • AQST Nasdaq
  • SMC NYSE
  • Market Cap
  • AQST 272.9M
  • SMC 321.0M
  • IPO Year
  • AQST 2018
  • SMC 2012
  • Fundamental
  • Price
  • AQST $3.25
  • SMC $25.93
  • Analyst Decision
  • AQST Strong Buy
  • SMC
  • Analyst Count
  • AQST 6
  • SMC 0
  • Target Price
  • AQST $10.67
  • SMC N/A
  • AVG Volume (30 Days)
  • AQST 1.6M
  • SMC 71.0K
  • Earning Date
  • AQST 08-05-2025
  • SMC 08-07-2025
  • Dividend Yield
  • AQST N/A
  • SMC N/A
  • EPS Growth
  • AQST N/A
  • SMC N/A
  • EPS
  • AQST N/A
  • SMC N/A
  • Revenue
  • AQST $54,228,000.00
  • SMC $444,383,000.00
  • Revenue This Year
  • AQST N/A
  • SMC N/A
  • Revenue Next Year
  • AQST $45.71
  • SMC N/A
  • P/E Ratio
  • AQST N/A
  • SMC N/A
  • Revenue Growth
  • AQST 5.29
  • SMC N/A
  • 52 Week Low
  • AQST $2.12
  • SMC $24.39
  • 52 Week High
  • AQST $5.80
  • SMC $45.89
  • Technical
  • Relative Strength Index (RSI)
  • AQST 54.57
  • SMC 48.10
  • Support Level
  • AQST $3.20
  • SMC $25.66
  • Resistance Level
  • AQST $3.61
  • SMC $27.01
  • Average True Range (ATR)
  • AQST 0.28
  • SMC 0.88
  • MACD
  • AQST -0.00
  • SMC 0.26
  • Stochastic Oscillator
  • AQST 50.44
  • SMC 79.58

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About SMC SUMMIT MIDSTREAM CORPORATION

Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.

Share on Social Networks: